Cargando…
The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry
OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear c...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302280/ https://www.ncbi.nlm.nih.gov/pubmed/25310855 http://dx.doi.org/10.3802/jgo.2015.26.1.19 |
_version_ | 1782353768133689344 |
---|---|
author | Mattes, Malcolm D. Lee, Jennifer C. Metzger, Daniel J. Ashamalla, Hani Katsoulakis, Evangelia |
author_facet | Mattes, Malcolm D. Lee, Jennifer C. Metzger, Daniel J. Ashamalla, Hani Katsoulakis, Evangelia |
author_sort | Mattes, Malcolm D. |
collection | PubMed |
description | OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) who underwent complete surgical staging and lymph node dissection. METHODS: Nine hundred seventy-two eligible patients diagnosed between 1998 to 2009 with International Federation of Gynecology and Obstetrics (FIGO) 1988 stage IA-IVA UPSC (n=685) or UCCC (n=287) were identified for analysis. Binomial logistic regression was used to determine risk factors for lymph node metastasis, with the incidence of pelvic and para-aortic lymph node metastases reported for each FIGO primary tumor stage. The Cox proportional hazards regression model was used to determine factors associated with overall survival. RESULTS: FIGO primary tumor stage was the only independent risk factor for lymph node metastasis (p<0.01). The incidence of pelvis-only and para-aortic lymph node involvement according to the FIGO primary tumor stage were as follows: IA (2.3%/3.8%), IB (7.5%/5.2%), IC (22.5%/16.9%), IIA (20.8%/13.2%), IIB (25.7%/14.9%), and III/IV (25.7%/24.3%). Prognostic factors for overall survival included lymph node involvement (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.09 to 1.85; p<0.01), patient age >60 years (HR, 1.70; 95% CI, 1.21 to 2.41; p<0.01), and advanced FIGO primary tumor stage (p<0.01). Tumor grade, histologic subtype, and patient race did not predict for either lymph node metastasis or overall survival. CONCLUSION: There is a high incidence of both pelvic and para-aortic lymph node metastases for FIGO stages IC and above uterine papillary serous and clear cell carcinomas, suggesting a potential role for lymph node-directed therapy for these patients. |
format | Online Article Text |
id | pubmed-4302280 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology |
record_format | MEDLINE/PubMed |
spelling | pubmed-43022802015-01-27 The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry Mattes, Malcolm D. Lee, Jennifer C. Metzger, Daniel J. Ashamalla, Hani Katsoulakis, Evangelia J Gynecol Oncol Original Article OBJECTIVE: In this study we utilized the Surveillance, Epidemiology and End-Results (SEER) registry to identify risk factors for lymphatic spread and determine the incidence of pelvic and para-aortic lymph node metastases in patients with uterine papillary serous carcinoma (UPSC) and uterine clear cell carcinoma (UCCC) who underwent complete surgical staging and lymph node dissection. METHODS: Nine hundred seventy-two eligible patients diagnosed between 1998 to 2009 with International Federation of Gynecology and Obstetrics (FIGO) 1988 stage IA-IVA UPSC (n=685) or UCCC (n=287) were identified for analysis. Binomial logistic regression was used to determine risk factors for lymph node metastasis, with the incidence of pelvic and para-aortic lymph node metastases reported for each FIGO primary tumor stage. The Cox proportional hazards regression model was used to determine factors associated with overall survival. RESULTS: FIGO primary tumor stage was the only independent risk factor for lymph node metastasis (p<0.01). The incidence of pelvis-only and para-aortic lymph node involvement according to the FIGO primary tumor stage were as follows: IA (2.3%/3.8%), IB (7.5%/5.2%), IC (22.5%/16.9%), IIA (20.8%/13.2%), IIB (25.7%/14.9%), and III/IV (25.7%/24.3%). Prognostic factors for overall survival included lymph node involvement (hazard ratio [HR], 1.42; 95% confidence interval [CI], 1.09 to 1.85; p<0.01), patient age >60 years (HR, 1.70; 95% CI, 1.21 to 2.41; p<0.01), and advanced FIGO primary tumor stage (p<0.01). Tumor grade, histologic subtype, and patient race did not predict for either lymph node metastasis or overall survival. CONCLUSION: There is a high incidence of both pelvic and para-aortic lymph node metastases for FIGO stages IC and above uterine papillary serous and clear cell carcinomas, suggesting a potential role for lymph node-directed therapy for these patients. Asian Society of Gynecologic Oncology; Korean Society of Gynecologic Oncology 2015-01 2015-01-08 /pmc/articles/PMC4302280/ /pubmed/25310855 http://dx.doi.org/10.3802/jgo.2015.26.1.19 Text en Copyright © 2015. Asian Society of Gynecologic Oncology, Korean Society of Gynecologic Oncology http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Original Article Mattes, Malcolm D. Lee, Jennifer C. Metzger, Daniel J. Ashamalla, Hani Katsoulakis, Evangelia The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry |
title | The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry |
title_full | The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry |
title_fullStr | The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry |
title_full_unstemmed | The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry |
title_short | The incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the SEER registry |
title_sort | incidence of pelvic and para-aortic lymph node metastasis in uterine papillary serous and clear cell carcinoma according to the seer registry |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4302280/ https://www.ncbi.nlm.nih.gov/pubmed/25310855 http://dx.doi.org/10.3802/jgo.2015.26.1.19 |
work_keys_str_mv | AT mattesmalcolmd theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT leejenniferc theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT metzgerdanielj theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT ashamallahani theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT katsoulakisevangelia theincidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT mattesmalcolmd incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT leejenniferc incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT metzgerdanielj incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT ashamallahani incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry AT katsoulakisevangelia incidenceofpelvicandparaaorticlymphnodemetastasisinuterinepapillaryserousandclearcellcarcinomaaccordingtotheseerregistry |